World Health Assembly opens in Geneva, Switzerland
The Seventy-ninth session of the World Health Assembly (WHA79) opened in Geneva, Switzerland today, with the election of Dr Víctor Elías Atallah Lajam of the Dominican Republic as the President of th…
/wha76-overview-of-assembly-hall.tmb-1200v.jpg?sfvrsn=5cd3d542_7)
The Seventy-ninth session of the World Health Assembly (WHA79) opened in Geneva, Switzerland today, with the election of Dr Víctor Elías Atallah Lajam
Read Full Story at WHO Health →Why This Matters
The election of Dr. Víctor Elías Atallah Lajam as President of the World Health Assembly sends a signal about the Dominican Republic’s growing diplomatic influence in global health governance. Beyond procedural leadership, the choice reflects shifting power dynamics in multilateral institutions, where Latin American and Caribbean nations have increasingly taken on central roles in shaping health priorities amid rising skepticism toward traditional Western-led approaches.
Background Context
The World Health Assembly, the decision-making body of the WHO, operates on consensus-driven diplomacy, but recent sessions have been marked by fractures over pandemic preparedness, funding disputes, and debates about the organization’s independence from political and corporate interests. Dr. Lajam’s election comes at a time when the WHO faces pressure to reform, particularly from countries frustrated by slow responses to global health crises and unequal access to medical countermeasures.
What Happens Next
The new presidency will likely steer discussions toward equity in health financing and the distribution of medical resources, with the Dominican Republic expected to advocate for smaller nations’ priorities in negotiations over the WHO’s pandemic accord. Observers will watch whether the assembly can bridge divides on controversial topics like intellectual property waivers for vaccines or the role of private sector involvement in health emergencies.
Bigger Picture
This leadership transition underscores a broader trend of regional blocs asserting more control over global health agendas, mirroring shifts seen in climate negotiations and trade talks. It also highlights the WHO’s evolving role as a battleground for competing visions of public health sovereignty, where sovereignty concerns increasingly clash with calls for centralized, data-driven responses to shared threats.
